All In MedTech

Device Trial Radar · NCT04735016

DiamondTemp Global Registry

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

545

Planned (sponsor's estimate)

Start

Apr 22, 2021

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Medtronic Cardiac Ablation SolutionsPublic (MDT)
Sponsor type
Industry
First posted
Feb 2, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The DiamondTemp™ Global Registry is a prospective, global, multi-center, observational post-market registry.

Conditions

  • Arrhythmia

Interventions

  • DiamondTemp™ Ablation SystemDevice

    A cardiac ablation will be performed using the DiamondTemp™ Ablation System.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from Recurrence at 12 MonthsTime frame: 12 Months
  2. Freedom from Device / Procedure Related Adverse EventsTime frame: 12 Months

Locations

21 sites in 12 countries. Site status is shown where the registry gives one.

  • Sunshine Coast University Hospital

    Birtinya, Australia

  • Fiona Stanley Hospital

    Murdoch, Australia

  • Universitair Ziekenhuis Brussel

    Jette, Belgium

18 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.